x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

MedTech Global Insights

What"s next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you"re an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.

science life sciences

All Episodes

01:56

Pure Global: Europe's AI MedTech Double Jeopardy...

MedTech Global Insights ·

2026/03/07

This week, we dissect the critical challenge facing AI MedTech innovators in the European Union. The convergence of the stringent Medical Device Regulation (MDR) and the new, formidable EU AI Act has created a complex web of overlapping requirements, potentially slowing innovation and creating massive compliance burdens.We explore how companies developing Software as a Medical Device (SaMD) must now navigate two separate, high-stakes regulatory pathways for a single product. This episode breaks

en

02:04

Pure Global: Europe's New MedTech Vigilance Unseen...

MedTech Global Insights ·

2026/03/06

In this episode, we dissect the EU's latest regulatory shift: the new Device-Specific Vigilance Guidance (DSVG) from the Medical Device Coordination Group. This seemingly minor update carries major consequences for MedTech manufacturers, aiming to harmonize incident reporting for high-risk devices across Europe. We explore how this move, while promoting consistency, significantly raises the bar for post-market data collection and operational readiness.Imagine your company produces a revolutionary

en

01:57

Brussels' AI Device Cybersecurity: Pure Global's...

MedTech Global Insights ·

2026/03/05

In this episode of MedTech Global Insights, we dissect the rapidly evolving regulatory landscape in the European Union. As AI and software-based medical devices become more prevalent, regulators are shifting their focus beyond clinical efficacy to a critical new area: cybersecurity.We explore the latest draft implementing acts and new harmonised standards discussed last week that are creating a complex new layer of requirements for MedTech innovators. This isn't just about IT; it's about patient

en

01:41

USA Recall Chaos: Pure Global on Post-Market Nightmares

MedTech Global Insights ·

2026/03/04

This week, we dissect the critical Class I recall of Olympus's High Flow Insufflation Units. We move beyond the headlines to explore the immense operational challenges and regulatory complexities of executing a global recall, highlighting the often-underestimated importance of a proactive Post-Market Surveillance (PMS) system.This episode is a must-listen for any MedTech professional who wants to understand the real-world consequences of a product failure. We reveal the hidden logistical nightmare

en

01:54

Pure Global: Europe's AI MedTech Rules & The New...

MedTech Global Insights ·

2026/03/03

This week on MedTech Global Insights, we dissect the bombshell news from Brussels. The European Commission has just released its new implementation guidance for the AI Act's application to medical devices, and the impact is immediate. This episode provides a critical analysis of the new rules, focusing on the significant hurdles now facing non-EU MedTech innovators. We explore the stringent new requirements for data governance, algorithm transparency, and post-market surveillance. We reveal how

en

01:45

US-EU Cybersecurity: Pure Global on The Harmonization...

MedTech Global Insights ·

2026/03/02

This week on MedTech Global Insights, we dissect the groundbreaking new cybersecurity guidance jointly pushed by the EU and FDA. This isn't just another regulation. it's a paradigm shift that redefines the requirements for all connected medical devices. We explore how this 'secure by design' mandate impacts everything from product development timelines to submission strategies and the hidden operational costs. For any MedTech company with a device that connects to a network, this episode is

en

01:40

FDA Cybersecurity Rules: Pure Global on Unseen...

MedTech Global Insights ·

2026/03/01

This week, MedTech Global Insights dives into the FDA's aggressive new stance on medical device cybersecurity. As devices become more connected, the risk of breaches has become a primary concern for regulators, forcing a massive shift in how companies approach product development and submission.We explore the practical impact of these new premarket requirements, from mandatory Software Bills of Materials (SBOMs) to the complexities of post-market surveillance. This is not just a compliance update;

en

02:08

USA's FDA QMSR Shockwave: Pure Global on Hidden...

MedTech Global Insights ·

2026/02/28

The U.S. FDA has officially replaced its long-standing Quality System Regulation (QSR) with the new Quality Management System Regulation (QMSR), aligning with the global ISO 13485 standard. This landmark decision promises to streamline global compliance but introduces critical new challenges. This episode of MedTech Global Insights explores the real-world impact of this change. We move beyond the headlines to dissect the so-called "ISO 13485 plus" model, revealing the subtle but crucial FDA

en

01:48

America's IVD Reckoning: Pure Global on the End of LDTs

MedTech Global Insights ·

2026/02/27

The FDA is finalizing a historic rule change, bringing thousands of Laboratory Developed Tests (LDTs) under the full umbrella of medical device regulation. This move ends decades of a special 'enforcement discretion' policy and will fundamentally reshape the diagnostics industry in the United States, impacting everyone from university hospitals to commercial labs.We unpack what this means for the entire MedTech ecosystem. The shift from a lab-centric framework to the FDA's rigorous quality system

en

01:50

U.S. SaMD & FDA's New Rules: Pure Global on The...

MedTech Global Insights ·

2026/02/26

In this episode of MedTech Global Insights, we dissect the FDA's unexpected new mandatory cybersecurity rules for connected medical devices. What was once guidance is now a critical requirement for market access, demanding continuous post-market surveillance and proactive threat modeling that has left many manufacturers scrambling to adapt.We explore the immediate consequences for startups, mid-size companies, and large enterprises, who now face significant unplanned costs and logistical

en

01:44

Pure Global: Dubai MedTech Signals & Investment Codes...

MedTech Global Insights ·

2026/02/25

The global MedTech landscape is shifting, and the recent MedTech World conference in Dubai just sent some powerful signals about the future. This episode unpacks the key trends, investment clues, and strategic insights from the heart of the Middle East's booming healthcare ecosystem. We go beyond the headlines to reveal what this means for startups, investors, and multinational firms looking to capture their share of this lucrative market.Imagine you are a US-based startup with a breakthrough

en

01:57

Pure Global: EU MedTech's New FDA Audit—Beyond ISO 13485

MedTech Global Insights ·

2026/02/24

This week, we dissect the monumental shift in the US market as the FDA's new Quality Management System Regulation (QMSR) takes full effect. This move, which aligns US regulations with the global ISO 13485 standard, is being celebrated as a major step towards global harmonization. However, this celebration might be premature for many international manufacturers. We explore the hidden complexities and regulatory traps buried within the new "harmonized" rule. Simply being ISO 13485 certified is no

en

02:21

Pure Global: USA's QMSR Shift, The ISO 13485 Gamble...

MedTech Global Insights ·

2026/02/23

The U.S. FDA has just enacted its most significant regulatory overhaul in decades, replacing the old Quality System Regulation (QSR) with the new Quality Management System Regulation (QMSR). This major shift harmonizes the FDA's framework with the international ISO 13485 standard, a move intended to streamline global compliance. However, this change introduces immediate and critical challenges for medical device manufacturers worldwide. This episode of MedTech Global Insights dives deep into what

en

02:12

USA MedTech: Pure Global on The FDA's 'Forever Audit'...

MedTech Global Insights ·

2026/02/22

The game has changed. This week, the US FDA implemented a 'Total Product Life Cycle' inspection model, shifting regulatory focus from a one-time market approval to a continuous, career-long scrutiny of your medical device. This episode of MedTech Global Insights breaks down what this means for manufacturers and why your old compliance strategies are no longer enough.We explore the practical consequences of this shift. Imagine your device has been on the market for seven years. Are you prepared for

en

02:10

Pure Global: USA QMSR Deadline & The Hidden Gaps...

MedTech Global Insights ·

2026/02/21

This episode of MedTech Global Insights dives into the critical February 2026 deadline for the FDA's new Quality Management System Regulation (QMSR). We explore why this major regulatory shift is more than just an alignment with the ISO 13485 international standard. We reveal the hidden complexities and specific FDA requirements that are catching many MedTech companies off guard. Discover why simply having an ISO 13485 certificate is not enough to ensure compliance and avoid costly delays or

en

01:43

USA Cybersecurity: The FDA's RTA Threat. A Pure...

MedTech Global Insights ·

2026/02/20

Last week, the FDA sent a clear message to the MedTech industry by halting a major device submission over cybersecurity flaws. This episode of MedTech Global Insights dissects the new reality of the FDA's "Refuse to Accept" policy and what it means for manufacturers. We go beyond the headlines to reveal the specific requirements that are now non-negotiable for market approval in the United States.This is a fundamental shift in regulatory enforcement, where a weak cybersecurity plan can completely

en

02:01

Pure Global: USA MedTech Cybersecurity & Its Hidden...

MedTech Global Insights ·

2026/02/19

The FDA's new cybersecurity rules are more than just a regulatory checklist; they're reshaping the landscape for MedTech investment and acquisitions. Many innovative startups are discovering that their market access and company valuation now hinge entirely on their cybersecurity preparedness, an area they may have overlooked.This episode of MedTech Global Insights explores the immediate business impact of these stringent new requirements. We uncover why a lack of cybersecurity documentation is

en

01:38

USA's AI MedTech: Pure Global on The New FDA...

MedTech Global Insights ·

2026/02/18

This week, we dissect the FDA's groundbreaking new draft guidance on AI/ML-enabled medical devices. This isn't just another regulation. it's a paradigm shift that redefines the rules for software as a medical device. We explore how the requirement for a "Predetermined Change Control Plan" (PCCP) is creating significant new hurdles for innovators in the MedTech space.We break down what this means for manufacturers, from startups to enterprise leaders. For instance, a company with a brilliant,

en

01:50

USA's AI Diagnostics: Pure Global on FDA's Hidden...

MedTech Global Insights ·

2026/02/17

This week on MedTech Global Insights, we dissect the FDA's surprising new focus on AI-powered medical devices. A recent public enforcement action has sent a clear message: pre-market approval is no longer enough. The agency is now intensely scrutinizing the hidden risks of post-market cybersecurity and algorithm performance. We break down what this regulatory shift means for MedTech innovators worldwide. From the challenge of 'data drift' to the unseen vulnerabilities in routine software updates,

en

01:59

Boston's Neurovascular Gambit: Pure Global on M&A Chaos

MedTech Global Insights ·

2026/02/16

In this episode, we dissect the massive acquisition of Penumbra by Boston Scientific. We go beyond the financial headlines to explore the immense, unseen regulatory and logistical challenges that lie ahead as these two MedTech giants merge their global operations. This is not just a story of market consolidation; it is a case study in navigating the treacherous waters of international compliance. The real challenge begins now: How does Boston Scientific integrate Penumbra's product portfolio across

en

191 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter